Following HE treatment, LX-2 cells showed a significant reduction in TGF-β protein levels, particularly at 25 and 50 μg/mL, while this reduction is less pronounced at the highest dose of HE that was tested in these experiments. This evidence concerns the gene TGFB1 and hereditary elliptocytosis.